Abiomed (ABMD) stock Forecast for 2021 – 2025

Abiomed (ABMD) stock Forecast for 2022 – 2026

Last update: 05-19-2022, 10:35

Sector: Healthcare

The share price of Abiomed, Inc. (ABMD) now

What analysts predict:: $354.17

52-week high/low: $379.3 / $227.25

50/200 Day Moving Average: $295.88 / $322.74

This figure corresponds to the average price over the previous 50/200 days. For Abiomed stocks, the 50-day moving average is the resistance level today.

For Abiomed stocks, the 200-day moving average is the resistance level today.

Are you interested in Abiomed, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Abiomed stock price in 2022, 2023, 2024, 2025, 2026. How much will one Abiomed share be worth in 2022 - 2026?

When should I take profit in Abiomed stock? When should I record a loss on Abiomed stock? What are analysts' forecasts for Abiomed stock? What is the future of Abiomed stock?

We forecast Abiomed stock performance using neural networks based on historical data on Abiomed stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Abiomed stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Abiomed shares. This happens once a day.




Historical and forecast chart of Abiomed stock

The chart below shows the historical price of Abiomed stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Abiomed stock price can be found in the table below.

Long-term forecasts by years.

Abiomed daily forecast for a month

Date Target Pes. Opt. Vol., %
May 21 238.89 237.34 240.33 1.26
May 22 236.63 234.44 241.06 2.83
May 23 232.48 230.74 236.49 2.49
May 24 229.64 227.34 232.56 2.30
May 25 230.15 226.30 231.42 2.26
May 26 235.33 232.57 239.98 3.19
May 27 232.45 228.21 234.37 2.70
May 28 231.17 229.15 233.94 2.09
May 29 235.27 232.16 236.98 2.08
May 30 237.45 234.42 240.60 2.63
May 31 233.23 230.14 236.33 2.69
Jun 01 236.15 234.73 240.76 2.57
Jun 02 240.93 238.40 245.15 2.83
Jun 03 246.77 245.05 250.48 2.22
Jun 04 249.86 245.49 254.29 3.59
Jun 05 254.11 252.39 257.98 2.21
Jun 06 258.11 255.21 261.27 2.38
Jun 07 258.11 255.40 260.63 2.05
Jun 08 256.11 251.88 258.22 2.52
Jun 09 252.46 249.87 254.48 1.84
Jun 10 253.85 251.63 257.91 2.50
Jun 11 256.96 252.33 259.33 2.77
Jun 12 254.39 251.78 257.95 2.45
Jun 13 255.02 252.92 256.55 1.44
Jun 14 260.00 256.68 261.75 1.98
Jun 15 259.74 255.00 262.46 2.93
Jun 16 253.50 249.38 255.78 2.57
Jun 17 252.74 248.38 255.97 3.05
Jun 18 254.01 250.90 255.53 1.85
Jun 19 248.04 244.32 249.96 2.31

Abiomed Daily Price Targets


Abiomed Stock Forecast 05-21-2022.

Forecast target price for 05-21-2022: $238.89. Negative dynamics for Abiomed shares will prevail with possible volatility of 1.242%.

Pessimistic target level: 237.34

Optimistic target level: 240.33


Abiomed Stock Forecast 05-22-2022.

Forecast target price for 05-22-2022: $236.63. Negative dynamics for Abiomed shares will prevail with possible volatility of 2.748%.

Pessimistic target level: 234.44

Optimistic target level: 241.06


Abiomed Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $232.48. Negative dynamics for Abiomed shares will prevail with possible volatility of 2.433%.

Pessimistic target level: 230.74

Optimistic target level: 236.49


Abiomed Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $229.64. Negative dynamics for Abiomed shares will prevail with possible volatility of 2.247%.

Pessimistic target level: 227.34

Optimistic target level: 232.56


Abiomed Stock Forecast 05-25-2022.

Forecast target price for 05-25-2022: $230.15. Positive dynamics for Abiomed shares will prevail with possible volatility of 2.213%.

Pessimistic target level: 226.30

Optimistic target level: 231.42


Abiomed Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $235.33. Positive dynamics for Abiomed shares will prevail with possible volatility of 3.089%.

Pessimistic target level: 232.57

Optimistic target level: 239.98


ABMD (ABMD) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 240.87 231.66 252.13 8.12
Jul. 235.75 231.54 245.57 5.71
Aug. 241.36 230.28 254.08 9.37
Sep. 224.33 210.80 236.73 10.95
Oct. 224.33 210.41 231.96 9.29
Nov. 214.99 200.74 225.95 11.16
Dec. 211.52 197.67 224.28 11.86

Abiomed forecast for this year


Abiomed Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $240.869. Pessimistic: $231.66. Optimistic: $252.13


Abiomed Stock Prediction for Jul 2022

An downtrend is forecast for this month with an optimal target price of $235.75. Pessimistic: $231.54. Optimistic: $245.57


Abiomed Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $241.361. Pessimistic: $230.28. Optimistic: $254.08


Abiomed Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $224.333. Pessimistic: $210.80. Optimistic: $236.73


Abiomed Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $224.333. Pessimistic: $210.41. Optimistic: $231.96


Abiomed Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $214.99. Pessimistic: $200.74. Optimistic: $225.95


Abiomed Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $211.518. Pessimistic: $197.67. Optimistic: $224.28




Abiomed (ABMD) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 217.63 211.71 227.81 7.06
Feb 213.75 200.30 217.92 8.09
Mar 228.10 215.30 234.89 8.34
Apr 224.42 212.59 237.96 10.66
May 207.63 196.86 219.28 10.22
Jun 208.34 197.89 217.72 9.11
Jul 215.24 202.98 220.91 8.12
Aug 220.91 211.34 225.80 6.40
Sep 219.22 210.65 232.27 9.31
Oct 211.02 202.77 214.61 5.52
Nov 226.99 214.64 234.51 8.47
Dec 221.59 211.04 230.63 8.49

Abiomed (ABMD) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 204.26 199.92 214.85 6.95
Feb 202.17 196.68 206.47 4.74
Mar 203.55 198.53 212.03 6.36
Apr 198.53 185.88 210.51 11.70
May 211.53 207.03 218.72 5.34
Jun 216.38 210.68 229.44 8.18
Jul 207.55 197.85 215.31 8.11
Aug 210.73 204.28 216.64 5.70
Sep 198.37 194.49 210.34 7.53
Oct 195.16 183.72 208.10 11.72
Nov 191.02 178.19 203.52 12.45
Dec 191.99 187.42 204.23 8.23



Abiomed (ABMD) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 204.88 195.65 218.29 10.37
Feb 207.67 194.43 214.02 9.15
Mar 200.61 193.28 209.31 7.66
Apr 207.43 203.20 220.48 7.84
May 217.48 205.28 223.77 8.26
Jun 232.45 226.92 236.41 4.01
Jul 250.24 235.77 260.45 9.47
Aug 261.72 250.82 273.73 8.37
Sep 255.94 242.89 267.90 9.34
Oct 253.98 236.93 260.46 9.03
Nov 252.25 242.60 267.26 9.23
Dec 261.69 250.12 274.14 8.76

Abiomed (ABMD) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 270.81 265.97 275.41 3.43
Feb 268.74 261.20 273.76 4.59
Mar 261.43 244.32 275.20 11.22
Apr 275.65 268.85 290.88 7.57
May 270.96 265.89 283.86 6.33
Jun 269.81 252.38 278.98 9.54
Jul 259.49 247.80 266.33 6.96
Aug 280.00 270.96 287.14 5.64
Sep 283.33 273.22 300.19 8.99
Oct 272.01 256.75 278.26 7.73
Nov 269.93 260.99 278.42 6.26
Dec 269.48 254.36 275.66 7.73

Abiomed information and performance

Abiomed is a manufacturer of medical implants, including the AbioCor artificial heart and impella. The company is headquartered in Danvers, Massachusetts and has three subsidiary offices: two in Germany in Berlin and Aachen and one in Japan. Michael R. Minogue joined Abiomed in 2004 and serves as CEO, Chairman and President.

Abiomed Address

22 CHERRY HILL DRIVE, DANVERS, MA, UNITED STATES

Market Capitalization: 11 761 085 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 284 438 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 86.65

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.75

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.98

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.049

Quarterly Revenue Growth YOY: 0.119

Trailing PE: 86.65

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 10.48

Enterprise Value (EV) /Revenue

EV To EBITDA: 42.14

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 45545000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.